Clearside Biomedical, Inc. (NASDAQ:CLSD) Q2 2023 Results Conference Call August 14, 2023 4:30 PM ET Company Participants Jenny Kobin - IR George Lasezkay - CEO Charlie Deignan - CFO Conference Call Participants Jon Wolleben - JMP Securities Shawn Kim - Jones Trading Rohit Bhasin - Needham & Company Jack Padavano - Stifel Yi Chen - H.C. Wainwright Operator Greetings, and welcome to the Clearside Biomedical Second Quarter 2023 Financial Results and Corporate Update Call. [Operator Instructions] Please note, t ...